Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma

Publication Date

2023

Content Type

Article

PubMed ID:

37864646

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS